Table 3.
Genes and Genetic Variations Studied |
Number of Subjects |
Ethnicity | Genotyping Method |
Outcomes | Reference |
---|---|---|---|---|---|
CAT rs1001179 | 201 patients and 97 controls |
Slovenian | TaqMan | Association between rs1001179 and AD and AUDIT scores | [89] |
CAT rs1001179 | 85 | African American |
TaqMan | No association | [28] |
GSTP1 rs1695 | 39 patients and 43 controls |
Central Brazilians |
Allele-specific PCR and sequencing | Association between rs1695 and AUD | [21] |
GSTM1 (*1, *2), GSTT1 (*1, *2) | 200 patients and 400 controls |
North Italian | PCR-RFLP | Association between the GSTM1 null genotype and ethanol intake | [90] |
ADH1B (*1, *2), ALDH2 (*1, *2), GSTM1 (*1, *2), GSTT1 (*1, *2), | 121 patients and 145 controls |
Central Indians |
PCR-RFLP | Association between ALDH*2/*2 and the GSTT1 null genotype with alcohol consumption |
[11] |
ADH2 (*1, *2, *3), ADH3 (*1, *2), ALDH2 (*1, *2) | 80 AD patients and 144 controls |
Han Chinese | PCR-RFLP | Protective role of ALDH*2/*2 against AD |
[107] |
ADH1B rs122994, ALDH2 rs671 | 34 AD patients and 121 controls |
Japanese | PCR-RFLP | Associations between ADH1B rs122994, ALDH2 rs671, and AD | [58] |
9 polymorphisms in ALDH2
and 41 in ADH |
4597 | Northern European |
Sequenom mass array |
Association between ADH1B rs1042026 and alcohol intake; an association of ADH1C rs1693482 and ADH5 rs1230165 with alcohol consumption |
[91] |
ADH1B (*1, *2) | 152 | Jewish American |
Enzymatic amplification followed by hybridization with allele-specific oligonucleotides |
Association between ADH1B*2 and lower rates of alcohol consumption and more unpleasant reactions | [95] |
ADH1A rs2276332, ADH1B rs1229984 and rs4147536, ADH1C rs11499823, rs4147541, and rs1693431, ALDH2 rs671, rs4646778, rs886205, rs4646775 | 5451 | Japanese | TaqMan SNP Genotyping Assays |
Significant association between ADH1B rs1229984 and ALDH2 rs671 with drinking behavior | [93] |
ADH2 (*1, *2, *3), ADH3 (*1, *2), ALDH2 (*1, *2) | 340 | Mission Indian | Allele-specific PCR | Association of ADH2*1 with AD and ADH2*3 with AD and a lower number of maximum drinks |
[99] |
ALDH1A1*2 and ALDH1A1*3 | 137 AD patients and 108 controls |
Trinidadian and Toboggan (either Africans or Indians) |
Sequencing | Association of ALDH1A1*2 with a lifetime diagnosis of AD and high levels of alcohol consumption | [104] |
175 SNPs in 17 alcohol-metabolizing genes |
1588 | European American | NA | Strong association between ADH1B rs1229984 and the DSM-IV symptom count and the maximum number of drinks |
[94] |
ADH2 (*1, *2), ADH3 (*1, *2), ALDH2 (*1, *2) | 34 AD patients and 92 controls |
New Zealand (White, Asian, and Polynesian (New Zealand Maori and others)) |
A newly developed DNA sequencing assay |
Protective role of ADH2*2 allele against AUD |
[100] |
110 SNPs in ADH7, ADH1C, ADH1B, ADH1A, ADH6, ADH4, ADH5 | NA | European American and African American |
Sequenom mass array system |
Significant associations between ADH4 rs1984362, rs4699718, rs3762894, rs4148886, rs4699714, rs7694646, rs1126672, DWSHpy188I, rs1042364, rs1042365, rs2602866, and rs2602846 and AUD | [101] |
103 SNPs in the ADH gene region | 812 | Northern and Southern European |
Sequenom mass array system |
Associations between ADH1B rs2018417, rs1229985, rs17033, and rs1789877; ADH1A rs931635, rs1229967, rs1618572, rs1230025, and rs2276332; rs3857224, and rs3762894 in the ADH6–ADH4 intergenic region and ADH4 rs1800759 with early and late stages of alcohol metabolism |
[97] |
ALDH2 (*1, *2) | 68 AUD patients and 232 controls |
Korean | PCR-RFLP | Association between ALDH2*1 and AUD | [105] |
ADH1B rs1159918, ADH1C rs1614972, ADH4 rs1042364, ALDH2 rs2238151 | 99 AUD patients and 100 controls |
Central-West Brazilians | TaqMan assay | Statistically significant association between ADH4 rs1042364, ALDH2 rs2238151, and AUD |
[102] |
ADH2 (*1, *2), ALDH2 (*1, *2) | 153 AUD patients and 153 controls | Japanese | PCR-RFLP | Association between ALDH2*1/*1 and ADH2*1/*1 with AUD | [98] |
ALDH1A1 rs348479, rs348472, rs610529, rs2288087, rs13959, rs348449, rs595958, rs918836 | 104 alcoholics and 201 controls |
Finnish | TaqMan | Association between ALDH1A1 rs348479 and rs610529 with AD | [103] |
~750,000 genomic variants | 71 heavy drinkers and 126 controls | Taiwanese | High-density SNP arrays |
Strong association between ALDH2 rs671 and drinking behavior |
[106] |
ADH1B rs1229984 | 5632 | European and African American |
KASPar assays or Sequenom |
Protective effect of ADH1B rs1229984 against AD | [92] |
43 SNPs | 808 AD patients and 1248 controls |
European | Illumina 660 genome-wide SNP array, Illumina BeadXpress platform using a VeraCode SNP panel |
Association between ADH1C rs1614972 and AD | [96] |
Not available (NA); alcohol dependence (AD); alcohol use disorder (AUD).